Drug · DIN 02444607
STRENSIQ
12 MG/0.3 ML SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since August 14, 2015.
- Drug Identification Number (DIN)
- 02444607
- Company (DIN owner)
- Alexion Pharma GmbhBaar, Switzerland
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Asfotase alfa A16AB13
- Class
- Human
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ASFOTASE ALFA | 40 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 14, 2015: NOC 17204New Drug Submission (NDS)
Other DINs named STRENSIQ
- DIN 02444615 · Marketed
- DIN 02444623 · Marketed
- DIN 02444631 · Marketed
- DIN 02444658 · Marketed